Karen Krasney G.'s Insider Trades & SAST Disclosures

Karen Krasney G.'s most recent trade in Capricor Therapeutics Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 60,000 60,000 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. 13 Dec 2024 8,000 28,047 (0%) 0% 1.4 11,120 Common Stock
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2024 5,000 0 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Dec 2024 3,000 0 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen Krasney G. EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 80,000 80,000 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
G. Krasney Karen EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 7,140 7,140 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 80,000 80,000 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 11,878 11,878 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Nov 2022 18,932 0 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. 03 Nov 2022 18,932 20,047 (0%) 0% 1.4 26,315 Common Stock
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 84,080 84,080 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 95,693 95,693 - - Stock Option (Right to Buy)
Capricor Therapeutics Inc
Karen G. Krasney EVP, GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2020 104,908 104,908 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades